Takeda Pharmaceutical Company Limited Expense Relating To Variable Lease Payments Not Included In Measurement Of Lease Liabilities
Takeda Pharmaceutical Company Limited (TKPHF) reported Expense Relating To Variable Lease Payments Not Included In Measurement Of Lease Liabilities of JPY 11.25 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilities · last filed 2025-06-25
| Period end | Expense Relating To Variable Lease Payments Not Included In Measurement Of Lease Liabilities 12 month |
|---|---|
| 2025-03-31 | 11.25B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 10.95B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 4.79B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 4.01B JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | 6.32B JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | 8.17B JPY 20-F · filed 2022-06-29 |